Guardforce AI Co., Limited (NASDAQ: GFAI) received a Nasdaq Minimum Bid Price Deficiency Notification Letter dated December 12, 2025, and announced the receipt on December 17, 2025. The letter states that the company’s share price has fallen below the required $1.00 minimum bid price for 30 consecutive business days.
Nasdaq has granted Guardforce AI a 180‑day cure period, ending June 10, 2026, to restore compliance by maintaining a closing bid price of at least $1.00 for ten consecutive trading days. Failure to meet this requirement will trigger delisting from the Nasdaq exchange, which would severely limit liquidity and access for investors.
The deficiency follows a pattern of past compliance lapses. Guardforce AI previously received a similar notice in March 2022 and regained compliance by April 2022, demonstrating the company’s ability to address such issues but also highlighting a recurring challenge in sustaining a $1.00 bid price.
Management has stated that it is monitoring the bid price closely and is evaluating measures to improve its financial position and operating results. The company’s recent financial performance shows modest progress: revenue for the year ended December 31, 2024, rose 0.2% to $36.3 million, gross profit increased 16.1%, and the net loss narrowed to $5.9 million. Positive adjusted net income was reported for the first half of 2025, indicating a trend toward profitability.
Despite these improvements, the share price remains below the Nasdaq threshold, reflecting ongoing headwinds such as limited market demand for the company’s AI‑driven robotics solutions and the broader volatility in the technology sector. The company’s strategy to transition to an AI‑centric business model, supported by a $23.4 million cash balance as of December 31, 2024, aims to generate new revenue streams and improve margins over the long term.
Analysts and investors are closely watching Guardforce AI’s ability to meet the cure deadline. A successful compliance period would restore Nasdaq listing status and provide a platform for future capital raising, while failure would force a delisting that could trigger a rapid decline in liquidity and valuation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.